House passes tax deduction; Device to detect Alzheimer's shows promise;

@FierceMedDev: Massachusetts med tech outfit wins $1M from NIH to develop pediatric stent system. Story | Follow @FierceMedDev

@StacyALawrence: ICYMI last week: FDA clears oral sleep apnea device, as search for CPAP alternatives continues. Story | Follow @StacyALawrence

@VarunSaxena2: FDA panel recommends stronger labeling, limiting use of power morcellation--agency may go farther. Article | Follow @VarunSaxena2

@EmilyWFierce: Global infectious diseases are infiltrating the Times' crossword puzzles. Here's a roundup of clues: More | Follow @EmilyWFierce

> The House of Representatives passed a tax-related bill that increases and makes permanent a "bonus depreciation" deduction of 50%. The bill, which must pass the Senate, was received favorably by AdvaMed due to its potential for American investment and job creation. Release

> Australian researchers shared their preliminary results on a noninvasive optical imaging device that can be used to detect early signs of Alzheimer's. Tomorrow, the researchers will present their findings at the Alzheimer's Association International Conference in Denmark. Story

> Orthocare Innovations' prosthetic foot, Magellan, has joined forces with Vicon's mobile app, Galileo, to monitor and send data on the foot's movement to a doctor-monitored website. The app also gives patients options to adjust their prosthetic to improve mobility and stability. Story

Biotech News

@FierceBiotech: Fresh off Phase III success, Otonomy shoots for an $86M IPO. Story | Follow @FierceBiotech

@JohnCFierce: I'm soon going offline for a week. will be holding down the fort. Please postpone all big news until I get back. :) | Follow @JohnCFierce

@DamianFierce: Via @WSJ, $ABBV + $SHPG would leapfrog $LLY. More (sub. req.) | Follow @DamianFierce

@EmilyMFierce: Like in Humans, Genes Drive Half of Chimp Intelligence, Study Finds via . Article | Follow @EmilyMFierce

> Does crowdfunding work in biotech? Item

> President's advisory group calls for clinical trial changes, incentives for antibiotics R&D. More

> Roche and Exelixis herald a Phase III victory for their melanoma combo. News

> President's advisory group calls for clinical trial changes, incentives for antibiotics R&D. Story

Pharma News

@FiercePharma: Top-read on FP this weekend: Sun issues third recall since announcing deal to buy Ranbaxy. Article | Follow @FiercePharma

@EricPFierce: ICYMI last week: Weak link in the supply chain. Pharmacist walks out of NY hospital with 1,500 oxycodone tabs. Report | Follow @EricPFierce

@CarlyHFierce: ICYMI: Solid PhIII brings Sanofi closer to blockbuster dengue sales. FierceVaccines story | Follow @CarlyHFierce

> Shire finally comes to AbbVie's buyout table, thanks to $53B-plus bid. Story

> Riled by $84,000 Sovaldi, Senate panel digs into Gilead's Pharmasset buy. More

> China indicts PI and his American wife for 'illegal' activities in GSK bribery probe. Report

> Teva's picked its next chairman, rebel investor Landa says--and he's not in favor. News

CRO News

> China's HD Bio teams with Marshall U. for cancer R&D. Article

> CMOs eye Russia for growth. Item

> InVentiv joins a nonprofit effort to make trials more efficient. News

> Risk-sharing CRO Ergomed banks $18.9M and awaits a U.K. IPO. Story

> U.K. CRO emerges from $100M in deals with plans for more M&A. Article

Biotech IT News

> Google creates new cash source for European biotech IT startups with $100M VC fund. News

> Row over IT focus of Europe's brain project prompts 280 scientists to threaten a boycott. Story

> PHT prioritizes Android over Apple in preparation for 'bring your own device' trials. Article

> FDA warns Gilead over 'misleading' paid search link. Item

> After working to mimic the brain for 9 years, Numenta reflects on limitations of today's hardware. Story

Animal Health News

> PEDv diagnostic hits market as vets predict 2.5 million more deaths. Story

> U.K. animal care company profits from generic pet meds. Article

> Industry Voices: How to win at animal health. Report

> Vets may soon be able to carry scheduled drugs. News

> Report: China animal vaccine market up by 26%. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.